Procept Biorobotics

PRCT

Market cap $1.09B

PRCT Hedge Fund Activity: Q1 2026 in Review

256 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Procept Biorobotics (PRCT) for Q1 2026, worth a combined $1.4B — down 21% from $1.77B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new PRCT positions and 46 closed out — a net gain of 1 holder — while 97 added to existing stakes and 67 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $31.8M. The largest seller was AllianceBernstein, cutting an estimated $91.3M.

• 256 institutional investors held Procept Biorobotics (PRCT) as of Q1 2026, down from 263 in Q4 2025.
• Funds reported $1.4B of Procept Biorobotics stock for Q1 2026, down 21% quarter-over-quarter.
• 47 funds opened new Procept Biorobotics positions in Q1 2026 and 46 closed out, a net change of +1 holder.
• The largest Procept Biorobotics buyer in Q1 2026 was Point72 Asset Management, an estimated $31.8M added.
• The largest Procept Biorobotics seller in Q1 2026 was AllianceBernstein, an estimated $91.3M sold.

Based on aggregated 13F filings for Q1 2026.